Hans Keirstead

Dr. Hans Keirstead is an internationally known stem cell expert and serial entrepreneur that led the development of a treatment that restored movement and sensory function to people with quadriplegic spinal cord injury, and a treatment for cancer that has saved the lives of people with melanoma, brain cancer, and ovarian cancer. He has led therapy development for immune disorders, motor neuron diseases, and retinal diseases, as well as a vaccine for COVID-19. Dr. Keirstead is the Founder and Chairman of Immunis, Inc., Founder, Chairman, and CEO of AIVITA Biomedical, and the CEO of the non-profit Human Immunome Project, a global initiative decoding the immune system. He has founded four successful biotechnology companies, returning significant value to investors and treatment to patients.